The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews

Lenacapavir is a promising new twice-yearly injection that's shown to be highly effective in preventing HIV infections, marking a significant step forward in the fight against the virus. As its rollout begins, there's cautious optimism mixed with concerns about equitable distribution, particularly in regions where HIV is most prevalent. This isn't just another drug; it's a potentially transformative tool in reducing new HIV cases, but ensuring it reaches those who need it most will be crucial in truly making a global impact.